Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Evaluation of drug utilization pattern of anticancer drugs in oncology department of a tertiary care teaching hospital of southern Rajasthan

Sandeep Kumar Kamlekar, Ankit Agarwal, Aasha Latha P, Sangita Gupta.




Abstract

Background: Cancer becomes major health burden on society, increased mortality rate in developing and developed countries. Chemotherapy plays a key role in the management of cancer. Drug utilization studies give an idea about the prescribing practice and characterize the early signals of irrational drug use.

Aims and Objective: The present study was designed to investigate the utilization pattern of anticancer drugs and incidence of cancer types at Oncology Department, Geetanjali Medical College and Hospital, Udaipur, Rajasthan.

Materials and Methods: One ninety two prescriptions of cancer effected patients were screened for anticancer drugs and supportive medications from February 1, 2019, to September 30, 2019, according to disease type, respectively.

Results: In our study, maximum cancer encountering age in both males and females was above 50 years, females are more predominant over males (female 53.64% vs. 46.35% males) with carcinoma of breast 15% followed by carcinoma of ovary 13% with carcinoma of lung 10% in males. Carboplatin 52.08% was the most commonly prescribed drug, followed by paclitaxel 45.31% and gemcitabine 33.85% along with adjuvants dexamethasone 100%, ranitidine 100%, and pantoprazole 35.93% successfully.

Conclusion: Carboplatin with other anticancer drugs was a safer combination for treating above-mentioned carcinomas.

Key words: Anticancer Drug; Drug Utilization; Oncology; Carcinoma






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.